WHO ICTRP trial
Effectiveness and safety of a remote multidimensional intervention program in…
ChiCTR2400092510 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting
Key facts
| Trial ID | ChiCTR2400092510 |
|---|---|
| Public title | Effectiveness and safety of a remote multidimensional intervention program in patients with type 2 diabetes mellitus combined with sarcopenia or possible sarcopenia: a randomized, single-blind, controlled study |
| Scientific title | Effectiveness and safety of a remote multidimensional intervention program in patients with type 2 diabetes mellitus combined with sarcopenia or possible sarcopenia: a randomized, single-blind, controlled study |
| Primary sponsor | Department of Endocrinology, Peking University First Hospital |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Recruiting |
| Study type | Interventional study |
| Countries | China |
| Conditions | Type 2 diabetes mellitus in combination with sarcopenia or possible sarcopenia |
| Interventions | Control group:Maintain existing medical management without specific remote multidimensional interventions.;intervention group:Receive a 12-week remote multidimensional comprehensive intervention program that included medical guidance… |
| Registration date | Nov 18, 2024 |
| Target size | Control group:17;intervention group:17 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: